Search

Your search keyword '"Yassine, Hadi M."' showing total 256 results

Search Constraints

Start Over You searched for: Author "Yassine, Hadi M." Remove constraint Author: "Yassine, Hadi M." Database Unpaywall Remove constraint Database: Unpaywall
256 results on '"Yassine, Hadi M."'

Search Results

1. Evaluation of Efficacy of Surface Coated versus Encapsulated Influenza Antigens in Mannose–Chitosan Nanoparticle-Based Intranasal Vaccine in Swine

2. Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting

3. Rodent-borne parasites in Qatar: A possible risk at the human-animal-ecosystem interface

5. Metabolic predictors of COVID-19 mortality and severity: a survival analysis

7. Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant

8. Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient

11. Exploring the natural products chemical space to abrogate the F3L-dsRNA interface of monkeypox virus to enhance the immune responses using molecular screening and free energy calculations

12. Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design

13. SARS‐CoV‐2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study

14. Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study

15. Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months

16. History of primary-series and booster vaccination and protection against Omicron reinfection

18. Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study

19. Seroprevalence of herpes simplex virus type 1 and type 2 among the migrant workers in Qatar

21. Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study

22. Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections

23. Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study

24. Assessment of Broadly Reactive Responses in Patients With MERS-CoV Infection and SARS-CoV-2 Vaccination

27. A turning point in COVID-19 severity and fatality during the pandemic: A national cohort study in Qatar

30. Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: An observational study

31. Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta infections

32. Bivalent mRNA-1273.214 vaccine effectiveness in Qatar

35. BNT162b2 antigen dose and SARS-CoV-2 omicron infection in adolescents

37. Protection against Reinfection with the Omicron BA.2.75 Subvariant

38. Screening and diagnostic testing protocols for HIV and Syphilis infections in health care setting in Qatar: Evaluation and recommendations

39. Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study

40. Short- and longer-term all-cause mortality among SARS-CoV-2- infected persons and the pull-forward phenomenon in Qatar

43. Effect of BNT162b2 antigen dosage on protection against SARS-CoV-2 omicron infection

45. 1966. Protection afforded by prior infection, vaccination, and hybrid immunity against symptomatic BA.1 and BA.2 Omicron infections.

46. Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study

48. Covid-19 Vaccine Protection among Children and Adolescents in Qatar

50. Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection

Catalog

Books, media, physical & digital resources